Annual EBITDA
-$396.56M$4.65M+1.16%
Summary
- Current Value
- As of today, GH annual EBITDA is -$396.56M, up +1.16% on
- Historical Performance
- GH annual EBITDA is up +20.51% over the past 3 years, down -73.03% over the past 5 years
- All-Time High Comparison
- GH annual EBITDA is currently -887.60% below its historical high of -$40.15M set on
- 3-Year Low Comparison
- GH annual EBITDA is +23.68% above its 3-year low of -$519.63M reached on
- Sector Comparison
- GH annual EBITDA is higher than 2.48% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$396.56M | +1.2% | +20.5% | -73.0% | -887.6% | |
| Quarterly EBITDA | -$110.22M | +4.6% | +17.3% | -27.3% | – | |
| TTM EBITDA | -$397.03M | +1.0% | +21.1% | -75.8% | – | |
| Price | $85.49 | +110.4% | +230.6% | -40.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $982.02M | +32.9% | +118.5% | +242.5% | +3789.3% | |
| Annual EPS | -$3.32 | +6.6% | +48.2% | -27.6% | -514.8% | |
| -$436.30M | +1.6% | +18.4% | -77.9% | -895.0% | ||
| Annual Net Income | -$416.28M | +4.6% | +36.4% | -69.0% | -802.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$396.56M | at high | |
| 5Y | -$229.19M | N/A | -73.0% |
| All | -$40.15M | -887.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$519.63M | +23.7% | |
| 5Y | -$519.63M | +23.7% | |
| All | -$519.63M | +23.7% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$396.56M | +1.2% | |
| -$401.21M | +22.8% | |
| -$519.63M | -4.2% | |
| -$498.91M | -29.1% | |
| -$386.35M | -68.6% |
| Year | Value | Change |
|---|---|---|
| -$229.19M | -235.4% | |
| -$68.34M | +20.4% | |
| -$85.81M | -20.2% | |
| -$71.41M | -77.8% | |
| -$40.15M | - |
FAQ
What is the current annual EBITDA of GH?
As of today, GH annual EBITDA is -$396.56M
What is 1-year change in GH annual EBITDA?
GH annual EBITDA is up +1.16% year-over-year
What is 3-year change in GH annual EBITDA?
GH annual EBITDA is up +20.51% over the past 3 years
How far is GH annual EBITDA from its all-time high?
GH annual EBITDA is currently -887.60% below its historical high of -$40.15M set on December 31, 2016
How does GH annual EBITDA rank versus sector peers?
GH annual EBITDA is higher than 2.48% of companies in Healthcare sector
When is GH next annual earnings release?
As of today, the next annual earnings release for GH has not been scheduled
Quarterly EBITDA
-$110.22M$20.64M-23.03%
Summary
- Current Value
- As of today, GH quarterly EBITDA is -$110.22M, down -23.03% on
- Historical Performance
- GH quarterly EBITDA is up +4.58% year-over-year, up +17.29% over the past 3 years
- All-Time High Comparison
- GH quarterly EBITDA is currently -809.59% below its historical high of -$12.12M set on
- 3-Year Low Comparison
- GH quarterly EBITDA is +40.84% above its 3-year low of -$186.31M reached on
- Sector Comparison
- GH quarterly EBITDA is higher than 2.83% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$110.22M | -23.0% | +4.6% | +17.3% | -27.3% | |
| Annual EBITDA | -$396.56M | – | +1.2% | +20.5% | -73.0% | |
| TTM EBITDA | -$397.03M | +1.3% | +1.0% | +21.1% | -75.8% | |
| Price | $85.49 | -16.2% | +110.4% | +230.6% | -40.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $281.27M | +6.1% | +39.4% | +121.7% | +259.1% | |
| Quarterly EPS | -$1.00 | -34.4% | -11.3% | +26.8% | -6.5% | |
| -$120.27M | -21.5% | +4.5% | +16.1% | -31.9% | ||
| Quarterly Net Income | -$128.49M | -38.6% | -15.8% | +8.2% | -38.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$89.59M | -23.0% | |
| 3Y | -$88.97M | -23.9% | |
| 5Y | -$86.56M | N/A | -27.3% |
| All | -$12.12M | -809.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$115.51M | N/A | +4.6% |
| 3Y | -$186.31M | +40.8% | |
| 5Y | -$186.31M | +40.8% | |
| All | -$186.31M | +40.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GH?
As of today, GH quarterly EBITDA is -$110.22M
What is GH quarterly EBITDA most recent change?
GH quarterly EBITDA was down -23.03% on December 31, 2025
What is 1-year change in GH quarterly EBITDA?
GH quarterly EBITDA is up +4.58% year-over-year
How far is GH quarterly EBITDA from its all-time high?
GH quarterly EBITDA is currently -809.59% below its historical high of -$12.12M set on March 31, 2018
How does GH quarterly EBITDA rank versus sector peers?
GH quarterly EBITDA is higher than 2.83% of companies in Healthcare sector
When is GH next earnings release?
The next earnings release for GH is on
TTM EBITDA
-$397.03M$5.29M+1.31%
Summary
- Current Value
- As of today, GH TTM EBITDA is -$397.03M, up +1.31% on
- Historical Performance
- GH TTM EBITDA is up +1.02% year-over-year, up +21.07% over the past 3 years
- All-Time High Comparison
- GH TTM EBITDA is currently -1373.32% below its historical high of -$26.95M set on
- 3-Year Low Comparison
- GH TTM EBITDA is +23.64% above its 3-year low of -$519.91M reached on
- Sector Comparison
- GH TTM EBITDA is higher than 2.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$397.03M | +1.3% | +1.0% | +21.1% | -75.8% | |
| Annual EBITDA | -$396.56M | – | +1.2% | +20.5% | -73.0% | |
| Quarterly EBITDA | -$110.22M | -23.0% | +4.6% | +17.3% | -27.3% | |
| Price | $85.49 | -16.2% | +110.4% | +230.6% | -40.2% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $982.02M | +8.8% | +32.9% | +118.5% | +242.5% | |
| TTM EPS | -$3.31 | -3.2% | +6.8% | +48.3% | -28.5% | |
| -$436.72M | +1.3% | +1.6% | +19.0% | -78.1% | ||
| TTM Net Income | -$416.28M | -4.4% | +4.6% | +36.4% | -69.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$397.03M | at high | |
| 3Y | -$397.03M | at high | |
| 5Y | -$225.80M | N/A | -75.8% |
| All | -$26.95M | -1373.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$419.46M | +5.3% | |
| 3Y | -$519.91M | +23.6% | |
| 5Y | -$519.91M | +23.6% | |
| All | -$519.91M | +23.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GH?
As of today, GH TTM EBITDA is -$397.03M
What is GH TTM EBITDA most recent change?
GH TTM EBITDA was up +1.31% on December 31, 2025
What is 1-year change in GH TTM EBITDA?
GH TTM EBITDA is up +1.02% year-over-year
How far is GH TTM EBITDA from its all-time high?
GH TTM EBITDA is currently -1373.32% below its historical high of -$26.95M set on September 30, 2017
How does GH TTM EBITDA rank versus sector peers?
GH TTM EBITDA is higher than 2.46% of companies in Healthcare sector
When is GH next earnings release?
The next earnings release for GH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- GH Official Website guardanthealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1576280/000157628026000013/0001576280-26-000013-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576280/000157628026000013/0001576280-26-000013-index.htm
- GH Profile on Yahoo Finance finance.yahoo.com/quote/GH
- GH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gh